References
- Light RW. Pleural diseases. 6th ed. Philadelphia: Lippincott Williams & Wilkins; 2013.
- Light RW. Pleural effusions. Med Clin North Am 2011;95:1055-70. https://doi.org/10.1016/j.mcna.2011.08.005
- Porcel JM, Light RW. Pleural effusions. Dis Mon 2013;59:29-57. https://doi.org/10.1016/j.disamonth.2012.11.002
- Diaz-Guzman E, Budev MM. Accuracy of the physical examination in evaluating pleural effusion. Cleve Clin J Med 2008;75:297-303. https://doi.org/10.3949/ccjm.75.4.297
- Brims FJ, Davies HE, Lee YC. Respiratory chest pain: diagnosis and treatment. Med Clin North Am 2010;94:217-32. https://doi.org/10.1016/j.mcna.2010.01.003
- Froudarakis ME. Diagnostic work-up of pleural effusions. Respiration 2008;75:4-13. https://doi.org/10.1159/000112221
- Porcel JM, Vives M. Etiology and pleural fluid characteristics of large and massive effusions. Chest 2003;124:978-83. https://doi.org/10.1378/chest.124.3.978
- Brixey AG, Luo Y, Skouras V, Awdankiewicz A, Light RW. The efficacy of chest radiographs in detecting parapneumonic effusions. Respirology 2011;16:1000-4. https://doi.org/10.1111/j.1440-1843.2011.02006.x
- Qureshi NR, Gleeson FV. Imaging of pleural disease. Clin Chest Med 2006;27:193-213. https://doi.org/10.1016/j.ccm.2006.02.001
- Qureshi NR, Rahman NM, Gleeson FV. Thoracic ultrasound in the diagnosis of malignant pleural effusion. Thorax 2009;64:139-43. https://doi.org/10.1136/thx.2008.100545
- Yilmaz U, Polat G, Sahin N, Soy O, Gulay U. CT in differential diagnosis of benign and malignant pleural disease. Monaldi Arch Chest Dis 2005;63:17-22.
- Patel IJ, Davidson JC, Nikolic B, Salazar GM, Schwartzberg MS, Walker TG, et al. Consensus guidelines for periprocedural management of coagulation status and hemostasis risk in percutaneous image-guided interventions. J Vasc Interv Radiol 2012;23:727-36. https://doi.org/10.1016/j.jvir.2012.02.012
- Raptopoulos V, Davis LM, Lee G, Umali C, Lew R, Irwin RS. Factors affecting the development of pneumothorax associated with thoracentesis. AJR Am J Roentgenol 1991;156:917-20. https://doi.org/10.2214/ajr.156.5.2017951
- Jones PW, Moyers JP, Rogers JT, Rodriguez RM, Lee YC, Light RW. Ultrasound-guided thoracentesis: is it a safer method? Chest 2003;123:418-23. https://doi.org/10.1378/chest.123.2.418
- Menzies SM, Rahman NM, Wrightson JM, Davies HE, Shorten R, Gillespie SH, et al. Blood culture bottle culture of pleural fluid in pleural infection. Thorax 2011;66:658-62. https://doi.org/10.1136/thx.2010.157842
- Hooper C, Lee YC, Maskell N; BTS Pleural Guideline Group. Investigation of a unilateral pleural effusion in adults: British Thoracic Society Pleural Disease Guideline 2010. Thorax 2010;65 Suppl 2:ii4-17.
- Romero-Candeira S, Fernandez C, Martin C, Sanchez-Paya J, Hernandez L. Influence of diuretics on the concentration of proteins and other components of pleural transudates in patients with heart failure. Am J Med 2001;110:681-6. https://doi.org/10.1016/S0002-9343(01)00726-4
- Bielsa S, Porcel JM, Castellote J, Mas E, Esquerda A, Light RW. Solving the Light's criteria misclassification rate of cardiac and hepatic transudates. Respirology 2012;17:721-6. https://doi.org/10.1111/j.1440-1843.2012.02155.x
- Porcel JM. Pleural fluid biomarkers: beyond the Light criteria. Clin Chest Med 2013;34:27-37. https://doi.org/10.1016/j.ccm.2012.11.002
- Villena V, Lopez-Encuentra A, Garcia-Lujan R, Echave- Sustaeta J, Martinez CJ. Clinical implications of appearance of pleural fluid at thoracentesis. Chest 2004;125:156-9. https://doi.org/10.1378/chest.125.1.156
- Kalomenidis I, Light RW. Eosinophilic pleural effusions. Curr Opin Pulm Med 2003;9:254-60. https://doi.org/10.1097/00063198-200307000-00002
- Putnam B, Elahi A, Bowling MR. Do we measure pleural fluid pH correctly? Curr Opin Pulm Med 2013;19:357-61. https://doi.org/10.1097/MCP.0b013e3283620844
- Mishra EK, Rahman NM. Factors influencing the measurement of pleural fluid pH. Curr Opin Pulm Med 2009;15:353-7. https://doi.org/10.1097/MCP.0b013e32832b98d4
- Heffner JE, Heffner JN, Brown LK. Multilevel and continuous pleural fluid pH likelihood ratios for evaluating malignant pleural effusions. Chest 2003;123:1887-94. https://doi.org/10.1378/chest.123.6.1887
- Porcel JM, Esquerda A, Bielsa S. Diagnostic performance of adenosine deaminase activity in pleural fluid: a single-center experience with over 2100 consecutive patients. Eur J Intern Med 2010;21:419-23. https://doi.org/10.1016/j.ejim.2010.03.011
- Sahn SA. Getting the most from pleural fluid analysis. Respirology 2012;17:270-7. https://doi.org/10.1111/j.1440-1843.2011.02100.x
- Skouras V, Kalomenidis I. Chylothorax: diagnostic approach. Curr Opin Pulm Med 2010;16:387-93. https://doi.org/10.1097/MCP.0b013e328338dde2
- Porcel JM, Bielsa S, Esquerda A, Ruiz-Gonzalez A, Falguera M. Pleural fluid C-reactive protein contributes to the diagnosis and assessment of severity of parapneumonic effusions. Eur J Intern Med 2012;23:447-50. https://doi.org/10.1016/j.ejim.2012.03.002
- Lee SH, Lee EJ, Min KH, Hur GY, Lee SY, Kim JH, et al. Procalcitonin as a diagnostic marker in differentiating parapneumonic effusion from tuberculous pleurisy or malignant effusion. Clin Biochem 2013;46:1484-8. https://doi.org/10.1016/j.clinbiochem.2013.03.018
- Porcel JM, Vives M, Cao G, Bielsa S, Ruiz-Gonzalez A, Martinez- Iribarren A, et al. Biomarkers of infection for the differential diagnosis of pleural effusions. Eur Respir J 2009;34:1383-9. https://doi.org/10.1183/09031936.00197208
- Janda S, Swiston J. Diagnostic accuracy of pleural fluid NTpro- BNP for pleural effusions of cardiac origin: a systematic review and meta-analysis. BMC Pulm Med 2010;10:58. https://doi.org/10.1186/1471-2466-10-58
- Han CH, Choi JE, Chung JH. Clinical utility of pleural fluid NTpro brain natriuretic peptide (NT-proBNP) in patients with pleural effusions. Intern Med 2008;47:1669-74. https://doi.org/10.2169/internalmedicine.47.1276
- Porcel JM. Utilization of B-type natriuretic peptide and NTproBNP in the diagnosis of pleural effusions due to heart failure. Curr Opin Pulm Med 2011;17:215-9. https://doi.org/10.1097/MCP.0b013e3283455cda
- Porcel JM, Vives M, Esquerda A, Salud A, Perez B, Rodriguez- Panadero F. Use of a panel of tumor markers (carcinoembryonic antigen, cancer antigen 125, carbohydrate antigen 15-3, and cytokeratin 19 fragments) in pleural fluid for the differential diagnosis of benign and malignant effusions. Chest 2004;126:1757-63. https://doi.org/10.1378/chest.126.6.1757
- Garcia LW, Ducatman BS, Wang HH. The value of multiple fluid specimens in the cytological diagnosis of malignancy. Mod Pathol 1994;7:665-8.
- Light RW. Update on tuberculous pleural effusion. Respirology 2010;15:451-8. https://doi.org/10.1111/j.1440-1843.2010.01723.x
- Prakash UB, Reiman HM. Comparison of needle biopsy with cytologic analysis for the evaluation of pleural effusion: analysis of 414 cases. Mayo Clin Proc 1985;60:158-64. https://doi.org/10.1016/S0025-6196(12)60212-2
- Maskell NA, Gleeson FV, Davies RJ. Standard pleural biopsy versus CT-guided cutting-needle biopsy for diagnosis of malignant disease in pleural effusions: a randomised controlled trial. Lancet 2003;361:1326-30. https://doi.org/10.1016/S0140-6736(03)13079-6
- Ferrer J, Roldan J, Teixidor J, Pallisa E, Gich I, Morell F. Predictors of pleural malignancy in patients with pleural effusion undergoing thoracoscopy. Chest 2005;127:1017-22. https://doi.org/10.1378/chest.127.3.1017
- Davies HE, Nicholson JE, Rahman NM, Wilkinson EM, Davies RJ, Lee YC. Outcome of patients with nonspecific pleuritis/ fibrosis on thoracoscopic pleural biopsies. Eur J Cardiothorac Surg 2010;38:472-7. https://doi.org/10.1016/j.ejcts.2010.01.057
Cited by
- PLEURAL EFFUSION: A REVIEW vol.1, pp.7, 2014, https://doi.org/10.18410/jebmh/2014/98
- The impact of pleural disease on the management of advanced ovarian cancer vol.138, pp.1, 2014, https://doi.org/10.1016/j.ygyno.2015.05.003
- Diagnostic significance of pleural fluid pH and pCO2 vol.64, pp.4, 2015, https://doi.org/10.1016/j.ejcdt.2015.05.004
- The role of thoracoscopy in management and outcome of stage II thoracic parapneumonic empyema: review of 148 cases vol.32, pp.3, 2014, https://doi.org/10.1007/s12055-016-0429-2
- Epidemiology and diagnosis of pleural tuberculosis in a low incidence country with high rate of immigrant population: A retrospective study vol.78, pp.None, 2014, https://doi.org/10.1016/j.ijid.2018.10.005
- Black pleural effusion: etiology, diagnosis, and treatment vol.35, pp.3, 2014, https://doi.org/10.1007/s12055-018-0756-6
- A 2‐year retrospective study on pleural effusions: A cancer centre experience vol.30, pp.6, 2014, https://doi.org/10.1111/cyt.12755
- Cytological-energy analysis of pleural effusions vol.56, pp.6, 2019, https://doi.org/10.1177/0004563219845415
- Loculated empyema in a neonate successfully treated with chest tube thoracostomy and antibiotics vol.31, pp.None, 2014, https://doi.org/10.1016/j.rmcr.2020.101274
- Adding positive airway pressure to mobilisation and respiratory techniques hastens pleural drainage: a randomised trial vol.66, pp.1, 2014, https://doi.org/10.1016/j.jphys.2019.11.006
- Cytological-energy analysis of pleural effusions with predominance of neutrophils vol.14, pp.None, 2014, https://doi.org/10.1177/1753466620935772
- Cutaneous myiasis with eosinophilic pleural effusion: A case report vol.9, pp.18, 2014, https://doi.org/10.12998/wjcc.v9.i18.4803
- Assessment of the diagnostic value of CEA, CA125, and CRP and their cut-off point for discrimination of exudative pleural effusions vol.3, pp.3, 2014, https://doi.org/10.21931/rb/2021.06.03.10
- Discrimination of Exudative Pleural Effusions Based on Pleural Adenosine Deaminase (ADA)-C-Reactive Protein (CRP) Levels, and Their Combination: An Observational Prospective Study vol.11, pp.9, 2014, https://doi.org/10.3390/jpm11090864
- Pleural cytokines MIF and MIP-3α as novel biomarkers for complicated parapneumonic effusions and empyema vol.11, pp.1, 2014, https://doi.org/10.1038/s41598-021-81053-6
- Histiocytic pleural effusion: the strong clue to malignancy vol.19, pp.1, 2021, https://doi.org/10.1186/s12957-021-02296-1